Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Financial Disclosure Clarification in: Surgical Treatment of Obesity in Adolescence

Financial Disclosure Clarification in: Surgical Treatment of Obesity in Adolescence Financial Disclosure Clarification: In an Editorial entitled “Surgical Treatment of Obesity in Adolescence,” published in the February 10, 2010, issue of JAMA (2010;303[6]:559-560), the financial disclosure section should have read: Dr Livingston reported that in 2008 he received an honorarium from Allergan for attending an advisory board meeting. He reported that he has had no direct or indirect financial relationship with Allergan before that single meeting and has had none since. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Financial Disclosure Clarification in: Surgical Treatment of Obesity in Adolescence

JAMA , Volume 303 (23) – Jun 16, 2010

Financial Disclosure Clarification in: Surgical Treatment of Obesity in Adolescence

Abstract

Financial Disclosure Clarification: In an Editorial entitled “Surgical Treatment of Obesity in Adolescence,” published in the February 10, 2010, issue of JAMA (2010;303[6]:559-560), the financial disclosure section should have read: Dr Livingston reported that in 2008 he received an honorarium from Allergan for attending an advisory board meeting. He reported that he has had no direct or indirect financial relationship with Allergan before that single meeting and has had none since.
Loading next page...
 
/lp/american-medical-association/financial-disclosure-clarification-in-surgical-treatment-of-obesity-in-MvzeTaKgjM
Publisher
American Medical Association
Copyright
Copyright © 2010 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2010.794
Publisher site
See Article on Publisher Site

Abstract

Financial Disclosure Clarification: In an Editorial entitled “Surgical Treatment of Obesity in Adolescence,” published in the February 10, 2010, issue of JAMA (2010;303[6]:559-560), the financial disclosure section should have read: Dr Livingston reported that in 2008 he received an honorarium from Allergan for attending an advisory board meeting. He reported that he has had no direct or indirect financial relationship with Allergan before that single meeting and has had none since.

Journal

JAMAAmerican Medical Association

Published: Jun 16, 2010

There are no references for this article.